The Sage Group

peripheral arterial and venous disease

Press Releases

According to THE SAGE GROUP, Almost 3 Million People in India Suffer From Critical Limb Ischemia Caused by Atherosclerotic Peripheral Arterial Disease

According to THE SAGE GROUP, In 2006 Over 800,000 Inpatient and OutpatientEndovascular Procedures Were Performed in the Lower Limbs Representing a $1 Billion U.S. Market to Treat Peripheral Arterial Disease.

THE SAGE GROUP Reports that in 2007 Approximately 2.8 million people in Western Europe Suffered from Critical Limb Ischemia.

THE SAGE GROUP Reports that in 2007 Between 4 and 8.4 Million Europeans Suffered from the Symptoms of Intermittent Claudication. A recent analysis published by THE SAGE GROUP concluded that between 3 and 6.7 million people in Western Europe have intermittent claudication (IC). An additional 800,000 to 1.7 million people in Eastern Europe suffer from IC.

THE SAGE GROUP Finds a Significant Number of New Pharmaceuticals in Clinical Trials for Treatment of Peripheral Arterial Disease. According to a report published by THE SAGE GROUP, research activity has intensified on pharmaceutical treatments for peripheral arterial disease (PAD)

THE SAGE GROUP Reports That Approximately 760,000 Revascularization Procedures Performed to Treat Peripheral Arterial Disease Are Potential Candidates for Perioperative Oral Antiplatelet Therapy

According to THE SAGE GROUP, Technological Innovation is the Key to the Future of Stenting in the Lower Limbs

THE SAGE GROUP Reports that in 2006 Approximately 2 Million People in the United States Suffered from Critical Limb Ischemia.

THE SAGE GROUP Commends the Launch of the National Peripheral Arterial Disease Awareness Campaign "Stay in Circulation: Take Steps to Learn About P.A.D."

THE SAGE GROUP Reports that the Acute Limb Ischemia (ALI) Market is Approximately $800 Million to $1.2 Billion. September 21, 2005.

Peripheral Arterial Disease (PAD)-Related Amputations Cost an Estimated $10 Billion, According to THE SAGE GROUP. Atlanta, Sept. 9, 2004.

Peripheral Arterial Disease Represents a Significant and Rapidly Growing Market Opportunity for Interventional Therapies, Particularly Endovascular Technologies.
Aug 25, 2004.

Peripheral Arterial Disease Seen as a Major New Market for Drug and Interventional Therapies, According to an Analysis Published by THE SAGE GROUP. May 21, 2003.

THE SAGE GROUP Research:

An estimated 2.8 million people in Western Europe have critical limb ischemia (CLI). Reflecting the ageing population, this number is projected to grow to 3.4 million by 2020.

(Critical Limb Ischemia, Volume II Western Europe Epidemiology)

.